Accelerated Infliximab Induction for Severe Lower Gastrointestinal Bleeding in a Young Patient with Crohn’s Disease: A Case Report

doi:10.12998/wjcc.v10.i2.733

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3783)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

246

WORD

105

HTML

1758

Figures (1-6)

182

Sum=2291

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

348

Download

1144

Sum=1492

Jan 14, 2022 (publication date) through Apr 16, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 14, 2022; 10(2): 733-740
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.733

Full Size Figure Download Figure

Figure 5 Endoscopic findings (8 wk after accelerated IFX induction). A, B: Eight weeks after accelerated IFX induction therapy, colonoscopy showed mucosal healing. IFX: Anti-TNFα antibody.

Citation: Zeng J, Shen F, Fan JG, Ge WS. Accelerated Infliximab Induction for Severe Lower Gastrointestinal Bleeding in a Young Patient with Crohn’s Disease: A Case Report. World J Clin Cases 2022; 10(2): 733-740
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/733.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.733